Clinical trial
Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy
NCT04905069 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- December 21, 2021
- Completion date
- December 31, 2030
- Enrollment
- 500 (actual)
- Sites
- 30
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer